Wellmune WGP® Receives Regulatory Approval in Australia
Biothera Products Available Through Pathway International
EAGAN, MN — May 8, 2008 — Wellmune WGP®, a natural immune-enhancing ingredient from Biothera, has been approved for use in complementary medicine products by Australia’s Therapeutic Goods Administration (TGA).
Biothera worked closely Pathway International, the company’s distributor in Australia and New Zealand, to obtain regulatory approval from the TGA, which ensures that therapeutic goods in Australia meet the requirements of the Therapeutic Goods Act of 1989.
“We are pleased that customers in Australia will have access to Wellmune wgp and other products from Biothera,” said Richard Mueller, Biothera president and chief executive officer.
About Wellmune WGP
Wellmune WGP is a functional food, beverage and dietary supplement ingredient available worldwide through Biothera and its distributors. This natural compound (gluco polysaccharide) is isolated from the cell walls of a proprietary strain of yeast. Wellmune WGP is patented, GRAS-approved, Kosher, non-allergenic and GMO-free. Numerous peer-reviewed studies support the safety and efficacy of Wellmune WGP, which is the culmination of years of research and a technology investment of more than $250 million. Wellmune WGP is available as a soluble and dispersible powder for ease of formulation in a wide range of foods and beverages, including clear liquids.
About Pathway International Pty Ltd.
Pathway International is the exclusive distributor in Australia and New Zealand for leading suppliers of high quality and innovative ingredients that add value to the health care and nutrition industries.
About Biothera, the Immune Health Company
Biothera is a biotechnology company dedicated to improving immune health. The company is developing pharmaceuticals that engage the innate immune system to fight cancer. Biothera also manufactures and markets Wellmune WGP and other food-grade ingredients that support healthy immune function to the functional food and beverage, nutritional supplement, cosmetic and animal nutrition markets.
Contacts:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606 (direct)
Wayne Coote
Managing Director
Pathway International
+61/ 2 9984 2700